P2 Gold Announces First Drill Results from Infill and Expansion Drilling at Gabbs

P2 Gold Inc. ("P2" or the "Company") (TSXV: PGLD) (OTCQB: PGLDF) reports results from the first six reverse circulation ("RC" ...

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The ...